Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Medicines are sometimes used for purposes other than those listed in the patient information leaflet. Do not use Tagrisso for unprescribed purposes. Do not give it to others even i···【more】
Article source：Captain MedicineRelease date：2026-02-11Recommended：81
Osimertinib is used for the prevention of recurrence in patients with non-small cell lung cancer after surgical resection of the tumor.What are the indications of Osimertinib?It is···【more】
Article source：Captain MedicineRelease date：2026-02-11Recommended：56
Selumetinib is an oral small‑molecule kinase inhibitor.How to Take SelumetinibSwallow the capsules whole with water. Do not open, chew, or crush the capsules.For patients unable to···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：95
Before taking selumetinib, tell your doctor about all your medical conditions, including: heart problems, eye problems, and liver problems.What are the important precautions when u···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：80
Selumetinib is used to treat type 1 neurofibromatosis (NF1) in pediatric patients aged 2 years and older who have symptomatic, inoperable plexiform neurofibromas (an orphan drug de···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：63
Selumetinib is used to treat patients with neurofibromatosis type 1 (NF1) with plexiform neurofibromas that cannot be surgically removed.What side effects may Selumetinib cause?Sel···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：57
The dosage of this medicine is individualized. Please follow the doctor’s instructions or the information on the medicine label. The following is only the average adult dosage. Do ···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：121
Sparsentan is indicated for slowing the progression of renal function decline in patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease deterior···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：102
The dosage of sparsentan is individualized; please use it in accordance with your doctor’s instructions or the information on the drug label.What are the daily precautions for spar···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：81
Sparsentan is indicated for slowing the decline in renal function in adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.What Pre···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：77
Belzutifan produced by Lucius Pharmaceuticals is a bioequivalent generic drug with the same mechanism of action as the marketed drug. It is indicated for the treatment of diseases ···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：68
The version of belzutifan produced by Lucius Pharmaceuticals is a more cost-effective generic drug, designed to provide renal cell carcinoma patients with the same active ingredien···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：73
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2272025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4532024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2332025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2462025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2262025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2552025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2352025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2172025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
